Latest Industry Insights

Industry Insight
Bruker’s Investment in RECIPE Expands Access to Chromatography-Free MS
Chromatography-free mass spectrometry boosts throughput, cuts costs and simplifies drug monitoring – learn how Bruker and RECIPE are leading the way.

Industry Insight
How At-Home Testing Is Changing Cervical Cancer Screening
In this interview, Technology Networks spoke with Kara Egan, CEO and co-founder of Teal Health, to learn more about how they are reshaping cervical cancer prevention.

Industry Insight
Shaping the Future of Newborn Screening
Dr. Madhuri Hegde discusses Revvity's role in the Generation Study, an ambitious initiative that will sequence the genomes of 100,000 newborns.

Industry Insight
Funding Will Advance Third-Party Verified Sustainability in Science
James Connelly discusses the importance of third-party verification and how recent funding will help accelerate the development of Impact Laboratories' digital sustainability tools.

Industry Insight
The Probiotic Designed To Work When Your Gut Is Under Attack
Technology Networks spoke with Dr. Jenny Bailey Cooper, co-founder and CEO of Ferryx, to learn the science behind its lead product, FerrocalmTM, and how its innovative strategy could reshape the future of gut health.

Industry Insight
Tick-Borne Illness Diagnosis Enters New Era With Multiplex Testing
Technology Networks spoke to Jason Barker, ND, clinical lab educator at Vibrant Wellness, to explore why co-infections from tick bites are frequently underdiagnosed and to examine current and future testing protocols of tick-borne diseases.

Industry Insight
A New Approach to Treating Osteoarthritis
In this interview, Technology Networks spoke with Dr. Francesco Dell’Accio and Dr. Suzanne Eldridge to explore the impact of osteoarthritis on patients, the goals of ReFleks and a novel approach to repairing osteochondral defects.

Industry Insight
European Consortium Will Advance Long-Read Sequencing in Clinics
A new pan-European network will integrate long-read sequencing into clinical practice, improving diagnosis of rare diseases and cancers.

Industry Insight
Why Good Science Is Key to Good Technology
In this opinion piece, Philipp Koellinger explores the changes required to level the playing field and accelerate both scientific and technological progress.

Industry Insight
How SPRQ Chemistry Is Breaking Barriers in DNA Sequencing
Dr. Aaron Wenger tells us about SPRQ chemistry, highlighting its unique benefits and role in expanding our understanding of rare diseases.
Advertisement